Summary
Maryland this week started a $500,000 fund for emerging biotechnology and pharmaceutical companies. The program will make grants to support promising health care research.
The initiative "is helping our state be No. 1. Whether it is venture capital funds or per capita income, Maryland's goal should always be becoming No. 1," Gov. Robert L. Ehrlich Jr., a Republican, said at a press conference Tuesday.See the full content of this document
Extract
Biotech Firms to Gain From New Fund
The cost of the program is being equally borne by health care products conglomerate Johnson & Johnson and Maryland's Technology Development Corp. (TEDC...
See the full content of this document
Sponsored links
